Literature DB >> 33651803

Optimising passive surveillance of a neglected tropical disease in the era of elimination: A modelling study.

Joshua Longbottom1,2, Charles Wamboga3, Paul R Bessell4, Steve J Torr1, Michelle C Stanton1.   

Abstract

BACKGROUND: Surveillance is an essential component of global programs to eliminate infectious diseases and avert epidemics of (re-)emerging diseases. As the numbers of cases decline, costs of treatment and control diminish but those for surveillance remain high even after the 'last' case. Reducing surveillance may risk missing persistent or (re-)emerging foci of disease. Here, we use a simulation-based approach to determine the minimal number of passive surveillance sites required to ensure maximum coverage of a population at-risk (PAR) of an infectious disease. METHODOLOGY AND PRINCIPAL
FINDINGS: For this study, we use Gambian human African trypanosomiasis (g-HAT) in north-western Uganda, a neglected tropical disease (NTD) which has been reduced to historically low levels (<1000 cases/year globally), as an example. To quantify travel time to diagnostic facilities, a proxy for surveillance coverage, we produced a high spatial-resolution resistance surface and performed cost-distance analyses. We simulated travel time for the PAR with different numbers (1-170) and locations (170,000 total placement combinations) of diagnostic facilities, quantifying the percentage of the PAR within 1h and 5h travel of the facilities, as per in-country targets. Our simulations indicate that a 70% reduction (51/170) in diagnostic centres still exceeded minimal targets of coverage even for remote populations, with >95% of a total PAR of ~3million individuals living ≤1h from a diagnostic centre, and we demonstrate an approach to best place these facilities, informing a minimal impact scale back.
CONCLUSIONS: Our results highlight that surveillance of g-HAT in north-western Uganda can be scaled back without substantially reducing coverage of the PAR. The methodology described can contribute to cost-effective and equable strategies for the surveillance of NTDs and other infectious diseases approaching elimination or (re-)emergence.

Entities:  

Mesh:

Year:  2021        PMID: 33651803      PMCID: PMC7954327          DOI: 10.1371/journal.pntd.0008599

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  38 in total

1.  Surveillance of smallpox.

Authors:  D A Henderson
Journal:  Int J Epidemiol       Date:  1976-03       Impact factor: 7.196

2.  Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group.

Authors:  R R German; L M Lee; J M Horan; R L Milstein; C A Pertowski; M N Waller
Journal:  MMWR Recomm Rep       Date:  2001-07-27

Review 3.  Use of mass media campaigns to change health behaviour.

Authors:  Melanie A Wakefield; Barbara Loken; Robert C Hornik
Journal:  Lancet       Date:  2010-10-09       Impact factor: 79.321

4.  Estimating and mapping the population at risk of sleeping sickness.

Authors:  Pere P Simarro; Giuliano Cecchi; José R Franco; Massimo Paone; Abdoulaye Diarra; José Antonio Ruiz-Postigo; Eric M Fèvre; Raffaele C Mattioli; Jean G Jannin
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

5.  Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.

Authors:  Francesco Checchi; Andrew P Cox; François Chappuis; Gerardo Priotto; Daniel Chandramohan; Daniel T Haydon
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

6.  Spatial modelling of healthcare utilisation for treatment of fever in Namibia.

Authors:  Victor A Alegana; Jim A Wright; Uusiku Pentrina; Abdisalan M Noor; Robert W Snow; Peter M Atkinson
Journal:  Int J Health Geogr       Date:  2012-02-15       Impact factor: 3.918

7.  Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with "screen, diagnose and treat" using innovative tools and strategies.

Authors:  Joseph Mathu Ndung'u; Alain Boulangé; Albert Picado; Albert Mugenyi; Allan Mortensen; Andrew Hope; Brahim Guihini Mollo; Bruno Bucheton; Charles Wamboga; Charles Waiswa; Dramane Kaba; Enock Matovu; Fabrice Courtin; Gala Garrod; Geoffrey Gimonneau; Georgina V Bingham; Hassane Mahamat Hassane; Inaki Tirados; Isabel Saldanha; Jacques Kabore; Jean-Baptiste Rayaisse; Jean-Mathieu Bart; Jessica Lingley; Johan Esterhuizen; Joshua Longbottom; Justin Pulford; Lingue Kouakou; Lassina Sanogo; Lucas Cunningham; Mamadou Camara; Mathurin Koffi; Michelle Stanton; Mike Lehane; Moise Saa Kagbadouno; Oumou Camara; Paul Bessell; Peka Mallaye; Philippe Solano; Richard Selby; Sophie Dunkley; Steve Torr; Sylvain Biéler; Veerle Lejon; Vincent Jamonneau; Wilfried Yoni; Zachary Katz
Journal:  PLoS Negl Trop Dis       Date:  2020-11-12

Review 8.  Epidemiology of human African trypanosomiasis.

Authors:  Jose R Franco; Pere P Simarro; Abdoulaye Diarra; Jean G Jannin
Journal:  Clin Epidemiol       Date:  2014-08-06       Impact factor: 4.790

9.  Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases.

Authors:  Nicholas G Reich; Justin Lessler; Jay K Varma; Neil M Vora
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

10.  Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.

Authors:  Charles Wamboga; Enock Matovu; Paul Richard Bessell; Albert Picado; Sylvain Biéler; Joseph Mathu Ndung'u
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.